Clinical Trials Browser

Phase 4 × pazopanib × Genitourinary × Clear all

NCT05949424 2023-11-29

OPTI-DOSE

Phase 4 Unknown

BreastGenitourinaryGynecologicHead & Neck

Breast Neoplasms, Carcinoma, Renal Cell, Ovarian Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT02555748 2021-01-12

SUP-R

Phase 4 Completed

Carcinoma, Renal Cell

NCT01521715 2017-08-23

FLIPPER

Phase 4 Completed

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell